(Fighting against New Coronary Pneumonia) Wang Zhigang: To be able to apply the new domestic crown vaccine, China will provide it to the world

  China News Agency, Beijing, June 7 (Li Jingze) "Vaccines are still the fundamental strategy for us to overcome the new coronavirus." Minister of Science and Technology Wang Zhigang said on the 7th that after the development and clinical trials are completed, the vaccine can be applied , China will "provide it to the world as a public product".

  The State Council Information Office of the People's Republic of China issued a white paper on "China Action Against New Coronary Pneumonia" (hereinafter referred to as "white paper") on the 7th and held a press conference. A reporter asked at the meeting whether China would "make domestic vaccines a global public product"?

  Wang Zhigang said that all countries put the development of vaccines in a very important position to fight against new coronary pneumonia. However, vaccine development is a very rigorous and very complex scientific activity, which is very difficult and has a long cycle. At the same time, because it is scientific research, it is also very challenging and uncertain.

  "Vaccine development must place safety, effectiveness and accessibility in a very important position." Wang Zhigang said that from the scientific research perspective, vaccine development generally requires virus isolation, laboratory vaccine construction, cell testing, and animals After trial, clinical research, and large-scale production, they can only be marketed and approved by the drug regulatory department.

  According to the white paper, China has carried out vaccine research and development in accordance with five technical routes including inactivated vaccines, recombinant protein vaccines, attenuated influenza virus vector vaccines, adenovirus vector vaccines, and nucleic acid vaccines. At present, four inactivated vaccines and one adenovirus vector vaccine have been approved for clinical trials. The overall R&D progress is the same as that of foreign countries, and the progress of some technical routes is in the international lead.

  "Establish an international cooperation expert database and carry out cooperation in vaccine research and drug development with relevant countries." The white paper also pointed out that China and relevant countries, the World Health Organization (WHO), the Epidemic Prevention Innovation Alliance (CEPI), and the Global Vaccine Immunization Alliance ( GAVI) and other scientific research cooperation to accelerate the development of vaccines and clinical trials of drugs.

  "Next, if the Chinese vaccine is ready for application after it has been developed and clinically tested, we will seriously implement President Xi Jinping's commitment at the 73rd WHO Conference and provide it as a public product to the world." Wang Zhigang It was said at the meeting. (Finish)